Skip to content
Catalyst

Eurycoma longifoliaFinding

Eurycoma longifolia has no detected effect on serum insulin-like growth factor 1 (IGF‑1)

no difference foundModerate evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“There were no significant differences between groups in IGF-1 at baseline and week 12 in both Physta® groups compared to placebo, but in Physta® 100 mg group, IGF-1 levels significantly decreased (P < 0.05) at week 12 compared to baseline (Table 4).”
Quoted verbatim from Effect of Eurycoma longifolia standardised aqueous root extract-Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study.
This finding among the 5 findings on its endpoint

Eurycoma longifolia

Serum insulin-like growth factor 1 (IGF-1)

no difference found

Who
Ageing men aged 50 to 70 years with baseline total testosterone below 300 ng/dL and BMI 18 to 30 kg/m2; Physta 100 mg and 200 mg arms each compared with placebo, week 12 only
Dose studied
100 mg or 200 mg once daily after breakfast for 12 weeks

Moderate evidencePMID 34262417 · 2021

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7FJB54VPWCHKFT20EJYZKTG